Free shipping on all orders over $ 500

Mc-VC-PAB-SN38 

Cat. No. M28881

All AbMole products are for research use only, cannot be used for human consumption.

Mc-VC-PAB-SN38  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Mc-VC-PAB-SN38 consists a cleavable ADC linker (Mc-VC-PAB) and a DNA topoisomerase I inhibitor (SN38). Mc-VC-PAB-SN38 can be used in the synthesis of antibody-drug conjugates (ADCs).

Chemical Information
Molecular Weight 991.05
Formula C51H58N8O13
CAS Number 1801838-28-7
Form Solid
Solubility (25°C) DMSO 28.57 mg/mL (ultrasonic)
Storage -20°C, protect from light, sealed
Related Drug-Linker Conjugates for ADC Products
MC-SN38 

MC-SN38 is a agent-linker conjugate composed of a potent microtubule-disrupting agent SN38 and a non-cleavable MC linker to make antibody agent conjugate (ADC).

DM4-SMCC 

DM4-SMCC is a agent-linker conjugate for ADC with antitumor activity by using DM4 (an antitubulin agent), linked via the non-cleavable SMCC linker.

Lys-SMCC-DM1

Lys-SMCC-DM1 (Lys-Nε-MCC-DM1) is a agent-linker conjugates for ADC that can inhibit tubulin polymerization.

Doxorubicin-SMCC 

Doxorubicin-SMCC is a agent-linker conjugate for ADC.

Mal-PEG4-VC-PAB-DMEA-PNU-159682 

Mal-PEG4-VC-PAB-DMEA-PNU-159682, a agent-linker conjugate for ADC, consists the ADC linker Mal-PEG4-VC-PAB and a potent ADC cytotoxin DMEA-PNU-159682.

  Catalog
Abmole Inhibitor Catalog




Keywords: Mc-VC-PAB-SN38  supplier, Drug-Linker Conjugates for ADC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.